Systematic lymphadenectomy for intermediate risk endometrial carcinoma treatment does not improve the oncological outcome

OBJECTIVE: To evaluate the indication and performance of systematic lymphadenectomy (SL) in Stage I endometrioid endometrial carcinoma (EEC), at intermediate risk (FIGO IAG2/G3, IBG1/G2) on recurrence, disease-free survival (DFS) and survival. STUDY DESIGN: 194 women underwent hysterectomies by lapa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Obstet Gynecol Reprod Biol X
Autors principals: Candido, Elaine C., Rangel Neto, Osmar F., Toledo, Maria Carolina S., Torres, José Carlos C., Cairo, Aurea A.A., Braganca, Joana F., Teixeira, Julio C.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Gynaecology: Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6687380/
https://ncbi.nlm.nih.gov/pubmed/31403112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eurox.2019.100020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars